IQVIA Holdings Inc. (IQV)

IQV Balance Sheet

Assets, liabilities, and equity analysis

IQV Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Total Current Assets	6.220B	6.220B	6.249B	5.979B	6.345B	5.911B	5.829B	5.632B	5.622B
Cash & Cash Equivalents	1.947B	1.947B	1.980B	1.814B	2.039B	1.740B	1.702B	1.572B	1.545B
Short-Term Investments	0.00	0.00	161.000M	158.000M	149.000M	136.000M	141.000M	140.000M	133.000M
Cash & Short-Term Investments	1.947B	1.947B	2.141B	1.972B	2.188B	1.876B	1.843B	1.712B	1.678B
Accounts Receivable	3.921B	3.921B	3.427B	3.314B	3.406B	3.311B	3.240B	3.250B	3.296B
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	29.675B	29.675B	29.944B	28.727B	28.632B	27.322B	26.899B	27.180B	26.398B
Property, Plant & Equipment	809.000M	809.000M	823.000M	824.000M	816.000M	768.000M	773.000M	772.000M	768.000M
Goodwill	16.544B	16.544B	16.616B	15.948B	15.611B	15.027B	14.710B	15.091B	14.477B
Intangible Assets	4.803B	4.803B	4.962B	4.707B	4.596B	4.503B	4.499B	4.734B	4.608B
Long-Term Investments	95.000M	95.000M	432.000M	405.000M	406.000M	383.000M	374.000M	320.000M	287.000M
Total Current Liabilities	8.329B	8.329B	8.338B	8.508B	7.572B	7.179B	6.957B	6.992B	6.620B
Accounts Payable	3.639B	3.639B	3.751B	3.550B	3.399B	3.559B	736.000M	3.434B	3.313B
Short-Term Debt	1.844B	1.844B	1.840B	2.164B	1.313B	1.222B	1.145B	1.219B	1.167B
Total Liabilities	23.326B	23.326B	23.314B	22.439B	22.846B	21.337B	20.832B	20.213B	19.684B
Long-Term Debt	232.000M	232.000M	14.109B	12.793B	14.177B	13.108B	12.838B	12.293B	12.091B
Total Debt	2.076B	2.076B	16.174B	15.190B	15.700B	14.507B	14.156B	13.700B	13.450B
Net Debt (Cash)	129.000M	129.000M	14.194B	13.376B	13.661B	12.767B	12.454B	12.128B	11.905B
Total Shareholders' Equity	6.221B	6.221B	6.503B	6.160B	5.778B	5.977B	6.067B	6.967B	6.714B
Common Stock	11.404B	11.404B	11.378B	3.000M	3.000M	3.000M	3.000M	3.000M	3.000M
Retained Earnings	7.699B	7.699B	7.425B	6.911B	6.580B	6.314B	6.065B	5.628B	5.343B
Current Ratio	0.75	0.75	0.75	0.70	0.84	0.82	0.84	0.81	0.85
Debt to Equity Ratio	0.33	0.33	2.49	2.47	2.72	2.43	2.33	1.97	2.00

IQV Annual Balance Sheet (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	6.249B	5.829B	5.596B	4.981B	4.763B	5.090B	4.126B	3.874B
Cash & Cash Equivalents	1.980B	1.702B	1.376B	1.216B	1.366B	1.814B	837.000M	891.000M
Short-Term Investments	161.000M	141.000M	120.000M	93.000M	111.000M	88.000M	62.000M	47.000M
Cash & Short-Term Investments	2.141B	1.843B	1.496B	1.309B	1.477B	1.902B	899.000M	938.000M
Accounts Receivable	3.427B	3.240B	3.413B	2.960B	2.609B	2.466B	2.638B	2.463B
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	29.944B	26.899B	26.681B	25.337B	24.689B	24.564B	23.251B	22.549B
Property, Plant & Equipment	823.000M	773.000M	819.000M	863.000M	903.000M	953.000M	954.000M	434.000M
Goodwill	16.616B	14.710B	14.567B	13.921B	13.301B	12.654B	12.159B	11.800B
Intangible Assets	4.962B	4.499B	4.839B	4.820B	4.943B	5.205B	5.514B	5.951B
Long-Term Investments	432.000M	374.000M	239.000M	162.000M	164.000M	162.000M	152.000M	142.000M
Total Current Liabilities	8.338B	6.957B	6.491B	5.578B	5.241B	4.558B	3.945B	3.534B
Accounts Payable	3.751B	736.000M	709.000M	645.000M	621.000M	581.000M	2.512B	437.000M
Short-Term Debt	1.840B	1.145B	718.000M	152.000M	91.000M	149.000M	100.000M	100.000M
Total Liabilities	23.314B	20.832B	20.569B	19.572B	18.647B	18.284B	16.988B	15.595B
Long-Term Debt	14.109B	12.838B	12.955B	12.595B	12.034B	12.384B	11.545B	10.907B
Total Debt	16.174B	14.156B	13.896B	13.011B	12.438B	12.904B	12.041B	11.007B
Net Debt (Cash)	14.194B	12.454B	12.520B	11.795B	11.072B	11.090B	11.204B	10.116B
Total Shareholders' Equity	6.503B	6.067B	6.112B	5.765B	6.042B	6.001B	6.003B	6.714B
Common Stock	11.378B	3.000M	3.000M	10.898B	3.000M	3.000M	11.049B	10.901B
Retained Earnings	7.425B	6.065B	4.692B	3.334B	2.243B	1.277B	998.000M	807.000M
Current Ratio	0.75	0.84	0.86	0.89	0.91	1.12	1.05	1.10
Debt to Equity Ratio	2.49	2.33	2.27	2.26	2.06	2.15	2.01	1.64

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC

89,000 employees

www.iqvia.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Ari Bousbib

View full financials